Immunogen, Inc. (NASDAQ: IMGN) kicked off on November 20, 2023, at the price of $15.66, down -7.26% from the previous trading day. During the day, the shares moved up to $15.995 and dropped to $14.77 before settling in for the closing price of $16.11. Over the past 52 weeks, IMGN has traded in a range of $3.61-$20.69.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 13.91%. While this was happening, its average annual earnings per share was recorded 107.45%. With a float of $259.43 million, this company’s outstanding shares have now reached $266.26 million.
The extent of productivity of a business whose workforce counts for 277 workers is very important to gauge. In terms of profitability, gross margin is +98.20, operating margin of -203.06, and the pretax margin is -203.81.
Immunogen, Inc. (IMGN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immunogen, Inc. is 2.57%, while institutional ownership is 91.21%. The most recent insider transaction that took place on Nov 17, was worth 1,255,479. In this transaction SVP & CHIEF BUSINESS OFFICER of this company sold 78,223 shares at a rate of $16.05, taking the stock ownership to the 36,966 shares. Before that another transaction happened on Nov 16, when Company’s SVP & CHIEF BUSINESS OFFICER sold 4,100 for $16.01, making the entire transaction worth $65,641. This insider now owns 36,966 shares in total.
Immunogen, Inc. (IMGN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported $0.1 earnings per share (EPS), higher than consensus estimate (set at $0.04) by $0.06. This company achieved a net margin of -204.93 while generating a return on equity of -92.61. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 107.45% per share during the next fiscal year.
Immunogen, Inc. (NASDAQ: IMGN) Trading Performance Indicators
Take a look at Immunogen, Inc.’s (IMGN) current performance indicators. Last quarter, stock had a quick ratio of 5.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.30, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Immunogen, Inc. (IMGN)
The latest stats from [Immunogen, Inc., IMGN] show that its last 5-days average volume of 5.62 million was superior to 5.31 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.51%. Additionally, its Average True Range was 0.90.
During the past 100 days, Immunogen, Inc.’s (IMGN) raw stochastic average was set at 30.39%, which indicates a significant increase from 27.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.98% in the past 14 days, which was lower than the 60.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.08, while its 200-day Moving Average is $12.38. Now, the first resistance to watch is $15.70. This is followed by the second major resistance level at $16.46. The third major resistance level sits at $16.92. If the price goes on to break the first support level at $14.48, it is likely to go to the next support level at $14.01. Assuming the price breaks the second support level, the third support level stands at $13.25.
Immunogen, Inc. (NASDAQ: IMGN) Key Stats
The company with the Market Capitalisation of 3.98 billion has total of 266,264K Shares Outstanding. Its annual sales at the moment are 108,780 K in contrast with the sum of -222,930 K annual income. Company’s last quarter sales were recorded 113,430 K and last quarter income was 30,750 K.